InvestorsHub Logo
Followers 131
Posts 11471
Boards Moderated 0
Alias Born 01/06/2010

Re: loanranger post# 75309

Saturday, 10/25/2014 6:23:07 PM

Saturday, October 25, 2014 6:23:07 PM

Post# of 402976

As far as I can tell...and this is the same question...am I wrong in my understanding that one (or two) doses of Brilacidin is as effective as the first two (or three) days of therapy with daptomycin?



Yes...that is what we know from the latest PR. I think it is safe to say that B is the statistical equal of D after 7 days as well....from the earlier pr. We know that because the p2a had just under 90% effectiveness for all arms combined. We also know that the results were better in the p2b. Even if D performed better this time, statistical equality with sample sizes of 50 is a pretty broad range. It is a certainty that at least one B arm is in that range, and almost a certainty that all 3 arms are in that range. When the statistical ranges narrow with the larger sample in p3, B will need to be close to D. That is why it would be nice to see the data sometime soon. The details are coming for sure in April (I think that is what the pr said), but of course I would like to have had them "yesterday".

I can't answer any of the other questions because I don't know the answer. More will be revealed...I think this one requires a little patience.

But everyone makes their own investment decisions.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News